This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore why new budgets fail and how to prevent it. Learn practical adjustments to build a durable plan that sticks.
26,203 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Target stock continues disappoint as the retailer unveils a growth plan amid slowing sales and mounting questions on ...
New data from the NAHB/Wells Fargo Cost of Housing Index shows a small improvement in affordability for 2025, driven ...
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
Fed leadership shifts toward a hawkish path as Waller signals higher policy risk. Markets price in tighter loans and ...
New York’s Fair and Transparent Real Estate Listings Act clears the Assembly and heads to the Senate, aiming to curb ...
A new Ethereum standard dubbed pERC-20 would hide balances and transfers by default, using zero-knowledge proofs to c...
Lululemon faced a sharp setback as the year unfolded, leaving investors asking if the brand can recover. This guide b...
In 2024, medicare paid $12.3 billion for a cluster of services that are now facing tighter coverage. This shift could...
Think it's late invest? You're not out of luck. Even if retirement feels distant, small, steady actions can compound ...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
When digital assets are seized, custody rules matter as much as the seizure itself. This article breaks down what hap...